ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,209,131, issued on Jan. 28, was assigned to Cantargia AB (Lund, Sweden).
"Anti-IL1RAP antibody compositions" was invented by Goran Forsberg (Eslov, Sweden), David Liberg (Lomma, Sweden), Kjell Sjostrom (Lund, Sweden) and Karin von Wachenfeldt (Lund, Sweden).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders."
The patent was filed on Aug. 15, 2019, under Application No. 17/267,157.
*For f...